日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Genetic evidence for PARP1 trapping as a driver of PARP inhibitor efficacy in BRCA mutant cancer cells.

遗传证据表明,PARP1 捕获是 BRCA 突变癌细胞中 PARP 抑制剂疗效的驱动因素。

Ribeiro Jonathan, Hansen Kjetil, van Beek Lotte, Stubbs Christopher, Frigola Joan, Talbot Sara, Bentouati Sabrina, Hall James, Wijnhoven Paul W G, Armenia Josh, Schimpl Marianne, Forment Josep V, Albertella Mark R, O'Connor Mark J, Illuzzi Giuditta

AZ14289671 is a highly selective and blood-brain barrier penetrant irreversible TKI that targets EGFRExon20 insertions.

AZ14289671 是一种高选择性且能穿透血脑屏障的不可逆 TKI,靶向 EGFRExon20 插入

Swaih Aisha M, Talbot Sara, Savoca Adriana, Thorpe Hannah, Flemington Vikki, Phillips Benjamin, Colclough Nicola, McCoull William, Radeva Veronika, Hargreaves David, Packer Martin J, Felisberto-Rodrigues Catarina, Thomson Clare, Orme Jonathan P, Deane Carly, Smith Aaron, Johnström Peter, Schou Magnus, McWilliams Lisa, Davey Paul, Enget Marianne, O'Neill Daniel, Cosulich Sabina, Floc'h Nicolas

Iron control of erythroid development by a novel aconitase-associated regulatory pathway

铁通过新的乌头酸酶相关调节途径控制红细胞的发育

Grant C Bullock, Lorrie L Delehanty, Anne-Laure Talbot, Sara L Gonias, Wing-Hang Tong, Tracey A Rouault, Brian Dewar, Jeffrey M Macdonald, Jason J Chruma, Adam N Goldfarb